1.0181
Finanzdaten der In 8 Bio Inc-Aktie (INAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.29%
4.935
|
5.266 | 5.033 | 3.967 | 5.201 |
| Operating Income/Loss |
6.07%
-4.781
|
-5.09 | -4.942 | -3.854 | -5.094 |
| Net Income/Loss |
6.07%
-4.781
|
-5.09 | -4.942 | -3.854 | -5.094 |
| Basic Average Shares |
0.00%
19.47
|
19.47 | - | 4.5377 | 4.1192 |
| Diluted Average Shares |
0.00%
19.47
|
19.47 | - | 4.5377 | 4.1192 |
| Basic Earnings Per Share |
3.85%
-0.25
|
-0.26 | - | -0.85 | -1.24 |
| Diluted Earnings Per Share |
3.85%
-0.25
|
-0.26 | - | -0.85 | -1.24 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):